Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001696868 | SCV000536150 | likely benign | not provided | 2018-11-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000950590 | SCV001096914 | likely benign | X-linked myopathy with postural muscle atrophy | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002379394 | SCV002674584 | likely benign | Cardiovascular phenotype | 2020-03-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV001696868 | SCV001925318 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001696868 | SCV001930816 | uncertain significance | not provided | no assertion criteria provided | clinical testing |